The data foundation that gets therapies to patients faster
Life science intelligence connects discovery, clinical, manufacturing, and commercial data into one governed foundation. This guide shows you how to build it without a multi-year overhaul.
Preferred Partner
7× Partner of the Year
2025 Design Partner of the Year
Download the guide
What’s inside the guide
- Architectural risk: How shifting to cell, gene, and decentralized trials turns fragmented data into a direct patient risk.
- Compliance-as-Code: How automating regulatory compliance enables faster hypothesis generation, adaptive trials, and real-time batch monitoring.
- End-to-end integration: How connecting data across discovery, manufacturing, and post-market reporting creates a real-time feedback loop.
- 4-week delivery roadmap: How to deploy fully governed, production-ready data products in repeatable 4-week sprints without a total system overhaul.
Ready to download?
Get the guide now.
What life science intelligence needs
Building this means layering a governed, GxP-compliant foundation on top of what clients already have: Snowflake, Veeva, and existing EDC and LIMS systems. phData Forgeâ„¢ delivers it sprint by sprint, each producing a production-ready data product in four weeks.
A missed manufacturing slot is a lost therapy for a patient with no time to spare.
— Deepti Cole, Industry VP, Life Sciences, phData
Frequently asked questions
What is life science intelligence?
Life science intelligence is the organizational capability to continuously translate data from every stage of the pharmaceutical lifecycle into decisions that reduce risk and speed patient access. It requires a unified data architecture: a shared, governed intelligence layer that connects previously siloed systems across discovery, clinical, manufacturing, and commercial rather than optimizing each function in isolation.
Why do pharma organizations get stuck in Pilot Purgatory?
Pilot Purgatory describes the pattern where AI pilots succeed on clean data extracts but fail when deployed to production. The cause is almost always a fragile data foundation: real-time data streams are messy, systems use incompatible data models, and GxP validation requirements aren’t built into the architecture from the start. A shared data foundation is the fix.
What is Compliance-as-Code and why does it matter in life sciences?
Compliance-as-Code is an architectural approach that embeds GxP validation, data lineage tracking, and audit trail generation directly into the data platform, instead of applying compliance as a manual, post-hoc documentation layer. Every data point becomes inherently traceable and explainable, cutting regulatory response cycles and reducing the manual reconciliation burden on clinical and quality operations teams.
What life science intelligence use cases should pharma organizations prioritize first?
phData recommends starting where data friction is most acute and most measurable: regulatory submission readiness, manufacturing batch release, or commercial supply chain visibility. Each has clear economic stakes, a defined data scope, and an existing Snowflake environment to deploy into. A single Forgeâ„¢ sprint validates the architecture and proves economic value before broader investment.
How are you building your life science intelligence platform?
Download the guide, or talk to us about scoping your first use case.